Avalo Therapeutics
Biotechnology Research • 
1500 Liberty Ridge Dr, Chesterbrook, United States • 21-50 Employees
Company overview
| Headquarters | 1500 Liberty Ridge Dr, Chesterbrook, Pennsylvania 19087, US |
| Phone number | +14105228707 |
| Website | |
| SIC | 283 |
| Keywords | Immunology |
| Founded | 2011 |
| Employees | 21-50 |
| Socials |
Key Contacts at Avalo Therapeutics
Garry Neil
Chair Of The Board Of Directors
Tammy Updegrove
Senior Director Quality Assurance
Ray Wetzler
Associate Director - Product Supply
Amanda Onuskanich
Senior Director, Clinical Program Management
Jason Lesinski
Associate Director Of Quality Assurance
Min Zhang
Director, Cmc
Mary Scavello
Director, Hr, Benefits & Administration
Maura Mcgovern
Director Sec Reporting & Technical Accounting
Emily Grisham Cooke
Director Clinical Operations
Avalo Therapeutics Email Formats
Avalo Therapeutics uses 5 email formats. The most common is {first initial}{last name} (e.g., jdoe@avalotx.com), used 35.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@avalotx.com | 55.9% |
{first name}{last name} | johndoe@avalotx.com | 32.4% |
{last name}{last name} | doedoe@avalotx.com | 5.9% |
{first initial} | j@cerecor.com | 2.9% |
About Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. For more information about Avalo, please visit www.avalotx.com. Our highly targeted therapeutics have strong scientific and clinical rationale that enable accelerated clinical development and increased probability of success. We are rapidly advancing a rich pipeline with broad clinical utility across Immunology, Immuno-oncology, and Rare Genetic Diseases. Our focus is the development of innovative therapies in areas of high unmet need within the fields of Rare Pediatric and Orphan Diseases.
Avalo Therapeutics revenue & valuation
| Annual revenue | $441,000 |
| Revenue per employee | $11,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,500,000 |
| Total funding | $200,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Avalo Therapeutics has 24 employees across 9 departments.
Departments
Number of employees
Funding Data
Explore Avalo Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Avalo Therapeutics Tech Stack
Discover the technologies and tools that power Avalo Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Font scripts
Web servers
JavaScript libraries
Tag managers
Webmail
JavaScript libraries
JavaScript libraries
Miscellaneous
Miscellaneous
UI frameworks
Analytics
Miscellaneous
France
Italy
United Kingdom
Czechia
Frequently asked questions
4.8
40,000 users
